200 related articles for article (PubMed ID: 27517838)
1. Association between prematurity and the evolution of psychotic disorders in 22q11.2 deletion syndrome.
Midbari Kufert Y; Nachmani A; Nativ E; Weizman A; Gothelf D
J Neural Transm (Vienna); 2016 Dec; 123(12):1491-1497. PubMed ID: 27517838
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and the evolution of psychosis in 22q11.2 deletion syndrome: a longitudinal 2-site study.
Gothelf D; Schneider M; Green T; Debbané M; Frisch A; Glaser B; Zilkha H; Schaer M; Weizman A; Eliez S
J Am Acad Child Adolesc Psychiatry; 2013 Nov; 52(11):1192-1203.e3. PubMed ID: 24157393
[TBL] [Abstract][Full Text] [Related]
3. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.
Mosheva M; Pouillard V; Fishman Y; Dubourg L; Sofrin-Frumer D; Serur Y; Weizman A; Eliez S; Gothelf D; Schneider M
Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):31-42. PubMed ID: 29934817
[TBL] [Abstract][Full Text] [Related]
4. Biological effects of COMT haplotypes and psychosis risk in 22q11.2 deletion syndrome.
Gothelf D; Law AJ; Frisch A; Chen J; Zarchi O; Michaelovsky E; Ren-Patterson R; Lipska BK; Carmel M; Kolachana B; Weizman A; Weinberger DR
Biol Psychiatry; 2014 Mar; 75(5):406-13. PubMed ID: 23992923
[TBL] [Abstract][Full Text] [Related]
5. Elevated Proinflammatory Markers in 22q11.2 Deletion Syndrome Are Associated With Psychosis and Cognitive Deficits.
Mekori-Domachevsky E; Taler M; Shoenfeld Y; Gurevich M; Sonis P; Weisman O; Weizman A; Gothelf D
J Clin Psychiatry; 2017; 78(9):e1219-e1225. PubMed ID: 29141125
[TBL] [Abstract][Full Text] [Related]
6. Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome.
Schneider M; Van der Linden M; Menghetti S; Glaser B; Debbané M; Eliez S
J Psychiatr Res; 2014 Jan; 48(1):86-93. PubMed ID: 24189154
[TBL] [Abstract][Full Text] [Related]
7. The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome.
Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
J Psychiatr Res; 2017 Sep; 92():124-131. PubMed ID: 28433949
[TBL] [Abstract][Full Text] [Related]
8. Premorbid adjustment and schizophrenia in individuals with 22q11.2 deletion syndrome.
Yuen T; Chow EW; Silversides CK; Bassett AS
Schizophr Res; 2013 Dec; 151(1-3):221-5. PubMed ID: 24262682
[TBL] [Abstract][Full Text] [Related]
9. Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome.
Monks S; Niarchou M; Davies AR; Walters JT; Williams N; Owen MJ; van den Bree MB; Murphy KC
Schizophr Res; 2014 Mar; 153(1-3):231-6. PubMed ID: 24534796
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and side effects of psychopharmacotherapy in individuals with 22q11.2 deletion syndrome with comorbid psychiatric disorders: a systematic review.
Mosheva M; Korotkin L; Gur RE; Weizman A; Gothelf D
Eur Child Adolesc Psychiatry; 2020 Aug; 29(8):1035-1048. PubMed ID: 30949827
[TBL] [Abstract][Full Text] [Related]
11. Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.
Mekori-Domachevsky E; Guri Y; Yi J; Weisman O; Calkins ME; Tang SX; Gross R; McDonald-McGinn DM; Emanuel BS; Zackai EH; Zalsman G; Weizman A; Gur RC; Gur RE; Gothelf D
Schizophr Res; 2017 Oct; 188():42-49. PubMed ID: 28041919
[TBL] [Abstract][Full Text] [Related]
12. Craniofacial dysmorphology in 22q11.2 deletion syndrome by 3D laser surface imaging and geometric morphometrics: illuminating the developmental relationship to risk for psychosis.
Prasad S; Katina S; Hennessy RJ; Murphy KC; Bowman AW; Waddington JL
Am J Med Genet A; 2015 Mar; 167A(3):529-36. PubMed ID: 25691406
[TBL] [Abstract][Full Text] [Related]
13. Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome.
Stoddard J; Niendam T; Hendren R; Carter C; Simon TJ
Schizophr Res; 2010 May; 118(1-3):118-21. PubMed ID: 20056393
[TBL] [Abstract][Full Text] [Related]
14. Deep psychophysiological phenotyping of adolescents and adults with 22q11.2 deletion syndrome: a multilevel approach to defining core disease processes.
Parker DA; Cubells JF; Imes SL; Ruban GA; Henshey BT; Massa NM; Walker EF; Duncan EJ; Ousley OY
BMC Psychiatry; 2023 Jun; 23(1):425. PubMed ID: 37312091
[TBL] [Abstract][Full Text] [Related]
15. A pilot study on immuno-psychiatry in the 22q11.2 deletion syndrome: A role for Th17 cells in psychosis?
Vergaelen E; Schiweck C; Van Steeland K; Counotte J; Veling W; Swillen A; Drexhage H; Claes S
Brain Behav Immun; 2018 May; 70():88-95. PubMed ID: 29567371
[TBL] [Abstract][Full Text] [Related]
16. Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome.
Niarchou M; Chawner SJRA; Fiksinski A; Vorstman JAS; Maeder J; Schneider M; Eliez S; Armando M; Pontillo M; Vicari S; McDonald-McGinn DM; Emanuel BS; Zackai EH; Bearden CE; Shashi V; Hooper SR; Owen MJ; Gur RE; Wray NR; van den Bree MBM; Thapar A;
Schizophr Res; 2019 Feb; 204():320-325. PubMed ID: 30093352
[TBL] [Abstract][Full Text] [Related]
17. Blood brain barrier permeability increases with age in individuals with 22q11.2 deletion syndrome.
Taler M; Mekori-Domachevsky E; Vergaelen E; Claes S; Serur Y; Dar S; Levy-Shraga Y; Weizman A; Swillen A; Gothelf D
World J Biol Psychiatry; 2022 Jul; 23(6):475-482. PubMed ID: 34854358
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and incidence of psychotic disorders in 22q11.2 deletion syndrome: a meta-analysis.
Provenzani U; Damiani S; Bersano I; Singh S; Moschillo A; Accinni T; Brondino N; Oliver D; Fusar-Poli P
Int Rev Psychiatry; 2022; 34(7-8):676-688. PubMed ID: 36786112
[TBL] [Abstract][Full Text] [Related]
19. Inter-rater reliability of subthreshold psychotic symptoms in individuals with 22q11.2 deletion syndrome.
Moore TM; Salzer D; Bearden CE; Calkins ME; Kates WR; Kushan L; Gallagher RS; Frumer DS; Weinberger R; McDonald-McGinn DM; Gur RE; Gothelf D
J Neurodev Disord; 2021 Jun; 13(1):23. PubMed ID: 34126928
[TBL] [Abstract][Full Text] [Related]
20. Neutrophils to lymphocytes ratio and psychosis in 22q11.2 deletion syndrome - Clinical and scientific implications.
Mekori-Domachevsky E; Taler M; Weinberger R; Guri Y; Dar S; Shani S; Dekel I; Weizman A; Gothelf D
Schizophr Res; 2021 May; 231():164-169. PubMed ID: 33866261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
